BRIEF published on 09/21/2026 at 07:50, 25 days 18 hours ago ALIKO Scientific Settles Dispute, US Subsidiary to Receive $2 Million Euronext Growth US Subsidiary Oncology Diagnostics Settlement ALIKO SCIENTIFIC
BRIEF published on 09/21/2026 at 07:50, 25 days 18 hours ago ALIKO Scientific concludes a $2 million deal Dispute ALIKO SCIENTIFIC Transactional Agreement Oncological Diagnosis American Subsidiary
PRESS RELEASE published on 09/21/2026 at 07:45, 25 days 18 hours ago Inside Information / Other news releases ALIKO Scientific settles dispute, US subsidiary to receive USD 2 million, related proceedings dismissed. ALIKO dedicated to oncology diagnostics US Subsidiary Oncology Diagnostics Settlement Dispute ALIKO SCIENTIFIC
BRIEF published on 09/15/2026 at 07:50, 1 month 1 day ago Aliko Scientific Expands in Brazil with Launch of Probantes ALIKO SCIENTIFIC FISH Probes Probantes Brazil Molecular Diagnostics Biodetecta Partnership
PRESS RELEASE published on 09/15/2026 at 07:45, 1 month 1 day ago Inside Information / Other news releases ALIKO Scientific launches Probantes in Brazil, establishing a new molecular diagnostic development and commercial platform for South America. Strategic agreement with Biodetecta enhances capabilities Brazil ALIKO SCIENTIFIC Probantes Molecular Diagnostic Biodetecta
BRIEF published on 09/07/2026 at 17:55, 1 month 9 days ago Aliko Scientific Launches U.S. Business Collaboration at ADLM 2026 U.S. Market ALIKO SCIENTIFIC ADLM 2026 Diagnostics Collaboration Partner International
PRESS RELEASE published on 09/07/2026 at 17:50, 1 month 9 days ago Inside Information / Other news releases Aliko Scientific partners with Partner International for U.S. business development at ADLM 2026, showing strong interest in oncology diagnostics technologies Oncology Diagnostics ALIKO SCIENTIFIC ADLM 2026 Partner International U.S. Business Development
BRIEF published on 08/24/2026 at 18:51, 1 month 23 days ago Aliko Scientific Updates Financial Position and Business Strategy Cash Flow Business Strategy Convertible Notes Financial Update Oncology Diagnostics
BRIEF published on 08/24/2026 at 18:47, 1 month 23 days ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 1 month 23 days ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
Published on 10/16/2026 at 23:35, 2 hours 55 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 3 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 3 hours 30 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/16/2026 at 22:55, 3 hours 35 minutes ago NioCorp Provides Preliminary Unaudited Financial Results for the Three-Month Period Ended September 30, 2026
Published on 10/16/2026 at 15:45, 10 hours 45 minutes ago IBC Advanced Alloys Reports Improved Financial Results for the Year Ended June 2026
Published on 10/16/2026 at 20:08, 6 hours 22 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 7 hours 10 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 7 hours 25 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 8 hours 12 minutes ago Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 8 hours 17 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 18:48, 7 hours 42 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/15/2026 at 18:50, 1 day 7 hours ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
